Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...

I-Mab (NASDAQ: IMAB) (the Company), a U.S.-based, global biotech company, focused on the development of precision ...

When surgeons repair tissues, they're currently limited to mechanical solutions such as sutures and staples, which can cause their own damage, or meshes and glues that may not adequately bond with ...

The breakome is a new layer in the multiomics landscape—alongside the genome, transcriptome, proteome, and interactome. While it hasn’t traditionally been included among these other omics, we consider ...

Advances in instruments and tools, as well as focused collaborations, improve accuracy and extend the range of applications.

Corcept revised its full-year 2025 revenue guidance to $850-900 million, with the midpoint of $875 million falling below the consensus estimate of $899 million. The company’s stock declined following ...

The court should adopt a narrow view of the Mann Act, the legal team states in a new filing, calling its application in Sean ...

Ocugen has scheduled a conference call and webcast for 8:30 a.m. ET today to discuss the financial results and recent business highlights. Ocugen’s executive leadership team will host the call, which ...

(NASDAQ:MRNA) today reported financial results and provided business updates for the second quarter of 2025. "In the last three months, we advanced our pipeline with positive Phase 3 flu vaccine ...

Knight Therapeutics Inc., (TSX: GUD) ("Knight") a pan-American (ex-USA) specialty pharmaceutical company, announced today that its Brazilian affiliate, United ...

Costing more than $9 million and funded by U.S taxpayers, the family planning supplies were intended for women in war zones, ...

When surgeons repair tissues, they're currently limited to mechanical solutions like sutures and staples, which can cause their own damage, or meshes ...